TAIPEI (The China Publish) — President Tsai Ing-wen (蔡英文) defended Medigen vaccines’ (高端疫苗) use of the “immunobridging” (免疫橋接) approach in an unique interview with Japanese media lately, explaining that it used the identical as that adopted in Japan.
“Immunobriding” compares the immune responses measured amongst recipients of the Medigen and different vaccines to deduce its total degree of safety.
This technique can shorten the time required for brand spanking new vaccines to be licensed, and she or he identified that related practices have been adopted in Japan lately.
Following many disputes over the procurement of home vaccines, Tsai identified that the home vaccines have achieved stellar ends in medical trials and added that Taiwan hopes to start out the vaccination course of as quickly as potential.
Whereas backing up the locally-produced vaccine, Tsai additionally remarked that Taiwan has confronted nice issue in procuring vaccines from the beginning.
As well as, the unique interview, revealed by Japanese month-to-month journal “Bungei Shunju” (文藝春秋), sees Tsai expressing gratitude in direction of international locations equivalent to Japan and america for donating vaccines to Taiwan.
